<!DOCTYPE html>
<html>
<head>
    <meta charset="utf-8">
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@picocss/pico@2/css/pico.classless.min.css">
    <title>Report 16-Sep-2025</title>
</head>
<body>
<main>
<a href="https://github.com/pathikrit/zeitgeist" target="_blank" rel="noopener" style="float: right;">
    <img src="https://github.githubassets.com/images/modules/logos_page/GitHub-Mark.png" alt="GitHub" width="30" height="30">
</a>
<h1>Daily Memo (Sep 16, 2025)</h1>
<hr />
<h2>Key Headlines &amp; Immediate News Flow</h2>
<ul>
<li><strong>Fed poised to cut rates for first time in 2025</strong> (widely anticipated; strong focus on implications for housing, credit, and risk appetite).</li>
<li><strong>US retail sales grow more than expected, but major indices pause near highs ahead of Fed move</strong>.</li>
<li><strong>Trump sues New York Times for $15bn defamation</strong>; media sector and tech litigation in focus.</li>
<li><strong>Geopolitical flashpoints:</strong>
<ul>
<li>Israel launches ground offensive in Gaza City; U.N. formally accuses Israel of genocide.</li>
<li>US, Qatar near defense deal following Israeli strike in Doha.</li>
<li>Trump heads to UK for official visit; political volatility and international relations in play.</li>
</ul>
</li>
<li><strong>Eli Lilly $5 billion drug facility in Virginia</strong> announced (amid active tariff threats on pharma).</li>
<li><strong>OpenAI, ChatGPT under scrutiny for AI teen-safety &amp; pending lawsuits, and remains IPO speculation target</strong>.</li>
<li><strong>TSMC, MediaTek, Apple: 2nm chips due to ramp up in late 2026, confirming ongoing US semiconductor production boom</strong>.</li>
<li><strong>Natural gas and oil remain volatile—significant price swings expected into year-end.</strong></li>
<li><strong>Asteroid 2025 FA22 'close approach' raises talk of catastrophe risk (no direct impact forecasted).</strong></li>
<li><strong>Upcoming UK election: surging political volatility, new parties in play.</strong></li>
<li><strong>US political polarization and potential new regulatory moves highlighted by FBI, shooting investigations, and state-level political violence.</strong></li>
</ul>
<hr />
<h2>Macro &amp; Thematic Insights</h2>
<h3>US Economic Outlook &amp; Policy</h3>
<ul>
<li>
<p><strong>Growth, Inflation, and Labor:</strong></p>
<ul>
<li>US GDP growth for 2025 is most likely in the 1.1–2.5% range, pointing to ongoing expansion but with some deceleration.</li>
<li>Core inflation is projected to remain elevated in the 3–4% range this year, suggesting persistence above the typical 2% Fed target. However, the likelihood of a re-acceleration is low.</li>
<li>Wages are expected to outpace inflation, supporting consumer spending resilience.</li>
<li>Unemployment is set to rise further, likely exceeding 4% by year-end, with hints of labor market softening. Sharp spikes (&gt;6–7%) are not central expectations right now but risk is upwardly skewed.</li>
</ul>
</li>
<li>
<p><strong>Rates, Dollar, and Debt:</strong></p>
<ul>
<li>Fed is expected to begin rate cuts imminently, and rates could drift into the 3.0–3.75% zone by mid/late 2026 depending on trajectory.</li>
<li>The USD faces pressure: high chance of US dollar index moving below last year's lows, with euro likely staging a notable recovery.</li>
<li>US national debt will continue to balloon, solidifying supply pressure on bonds. Sub-4% GDP debt ratio thresholds are not immediate, but ceiling risks grow in outer years.</li>
</ul>
</li>
<li>
<p><strong>Recession Risks:</strong></p>
<ul>
<li>Both US and global risk of recession over the next 18 months remains modestly elevated, but not base case. Major risks are more pronounced in the UK, Germany, and Japan, while China downturn risk is currently seen as lower.</li>
<li>Fiscal and trade volatility, with Trump likely to revisit tariffs (notably on China, Mexico, Taiwan, South Korea, Japan, Canada, and EU), and pressure for new trade agreements.</li>
</ul>
</li>
</ul>
<h3>International Macro</h3>
<ul>
<li><strong>Political &amp; FX Volatility:</strong>
<ul>
<li>UK politics remain in flux, with non-traditional and right-wing parties gaining traction and potential for further GBP swings post-election.</li>
<li>Tariff and trade volatility expected to remain high, especially should Trump administration solidify or escalate trade actions.</li>
<li>China is unlikely to overtake US in GDP by 2030, but ongoing tension ensures continued capital rotation, FX volatility, and risk premium for China exposure.</li>
</ul>
</li>
</ul>
<h3>Energy, Climate, and Commodities</h3>
<ul>
<li>
<p><strong>Energy Transition:</strong></p>
<ul>
<li>Progress on US and EU climate goals is in doubt. India more likely to meet targets, suggesting future competitive opportunities in Indian energy and climate-aligned themes.</li>
<li>Global primary energy mix through 2030 will remain dominated by coal and oil, with renewables continuing to grow but not to leading status yet.</li>
<li>US solar capacity buildout will be strong but below the most aggressive forecasts.</li>
<li>Natural gas prices expected to remain heightened; oil to stay volatile with possible downside shocks.</li>
</ul>
</li>
<li>
<p><strong>Climate and Extreme Events:</strong></p>
<ul>
<li>Major earthquake risk in California/Japan and asteroid impact remain low-probability but high-severity tail risks, underscoring the environment for catastrophe bonds and select REITs.</li>
<li>CO₂ levels will breach new records by 2030, raising long-run physical and policy risk profiles for emissions-intensive sectors.</li>
</ul>
</li>
</ul>
<hr />
<h2>Sector &amp; Theme-Level</h2>
<h3>Technology &amp; AI</h3>
<ul>
<li>
<p><strong>IPO Pipeline:</strong></p>
<ul>
<li>The IPO market is stirring, with Ramp, Klarna, and OpenAI generally the likeliest major entrants, but actual announcements remain subject to macro and risk sentiment.</li>
<li>Tech and AI are remaining at the innovation forefront, with US semiconductor production hitting robust growth in 2025. Supply chain investment remains strong.</li>
</ul>
</li>
<li>
<p><strong>Litigation/Regulatory Risks:</strong></p>
<ul>
<li>Amazon and Apple are at high risk of being legally labeled monopolies before decade’s end, which could prompt aggressive antitrust action and impact business models.</li>
<li>Litigation involving large AI companies (OpenAI, Anthropic, etc.) is set to continue, with material risk of substantial damages awarded, feeding regulatory risk premium.</li>
<li>Ongoing New York Times litigation with OpenAI and defamation lawsuits involving political figures could become pivotal in shaping the legal boundaries for media and tech.</li>
</ul>
</li>
<li>
<p><strong>Hardware:</strong></p>
<ul>
<li>Apple launches its latest Watch Series and iOS update, but battery issues may generate short-term noise. TSMC/MediaTek roadmaps reinforce US and allied semiconductor competitiveness.</li>
</ul>
</li>
</ul>
<h3>Financials &amp; Fintech</h3>
<ul>
<li>Several leading private fintechs (Ramp, Klarna) are more likely to IPO in the near term, but Stripe and Brex timelines lag.</li>
<li>Additional financial sector risks may arise from a broadened competitive/IPO landscape, regulatory scrutiny, and rapid tech shifts.</li>
</ul>
<h3>Healthcare &amp; Biotech</h3>
<ul>
<li>Multiple new FDA drug approvals expected before year-end (notably Donidalorsen, Sebetralstat), with continued high pace. However, a true cure for Type 1 diabetes or a law to curb pharma monopolies remains a tail event.</li>
<li>Eli Lilly is making a significant domestic investment with a new $5B facility—the company is positioning itself defensively against future tariffs and supply risk.</li>
<li>Psychedelic drug approvals may upend select biotech business models.</li>
<li>Pharma tariffs and regulatory changes remain a live risk if Trump administration pursues aggressive trade policy—healthcare supply chains and pricing to watch.</li>
</ul>
<h3>Energy, Industrial &amp; Materials</h3>
<ul>
<li>High volatility in commodities—oil likely to remain under pressure, but sharp upside not base case. Natural gas expected to stay tight.</li>
<li>Copper tariffs are feasible, elevating cost risks for industrials/electronics, and possibly creating short-term distortions in global supply chains.</li>
<li>Slow progress on fusion, not investment relevant pre-2035.</li>
</ul>
<h3>Consumer &amp; Entertainment</h3>
<ul>
<li>Media sector (e.g., Live Nation) faces high monopoly/regulatory risk, especially as courts are inclined to rule against sector leaders.</li>
<li>Streaming/content space sees robust innovation and audience engagement gains (Emmys reach a new high).</li>
<li>Consumer strength to be reinforced by solid wage growth, but sentiment risk lingers, especially around polarizing social issues.</li>
</ul>
<h3>Other Sectors</h3>
<ul>
<li>Aerospace likely to see significant headlines with SpaceX and Starlink progress, but IPOs not imminent.</li>
<li>Sports business (NBA, UFC) eyes expansion and new revenue streams.</li>
</ul>
<hr />
<h2>Individual Company/Name Watch</h2>
<ul>
<li><strong>Apple</strong>: Imminent regulatory and antitrust threats; new product launches (Watch, iOS) could face public scrutiny over technical hiccups.</li>
<li><strong>Amazon</strong>: Facing real risk of a monopoly ruling; watch for structural business and regulatory shifts.</li>
<li><strong>Eli Lilly</strong>: Massive capex push in US; resilience against supply chain and tariff shocks.</li>
<li><strong>OpenAI</strong>: Lawsuits escalating; media, legal, and regulatory risk may impact broader AI sector sentiment.</li>
<li><strong>Live Nation</strong>: Monopoly ruling probable, which could trigger business model shifts.</li>
</ul>
<hr />
<h2>Actionable Takeaways</h2>
<ul>
<li><strong>Risk/reward in equities remains favorable but volatility, policy events, and new political risk will define Q4 and 2026.</strong></li>
<li><strong>Bond yields are likely topping out—select duration risk is now more favorable, but inflation-linked assets should still be hedged.</strong></li>
<li><strong>USD weakening is a likely theme—global equity/international positions (notably EUR, India's climate and energy sectors) may see relative outperformance.</strong></li>
<li><strong>Tilt toward US domestic manufacturers and supply chain “onshoring” beneficiaries, particularly in tech, pharma, and renewables.</strong></li>
<li><strong>Remain vigilant on litigation/regulatory risk for mega-cap tech/AI and healthcare.</strong></li>
<li><strong>Diversify with exposure to real assets, including catastrophe and climate hedges, as geopolitical and environmental tail-risks climb.</strong></li>
</ul>

</main>
</body>
</html>
